Key result
Polymerase chain reaction technology has revolutionized tuberculosis diagnostics in India, highlighting a critical need for indigenous development of molecular diagnostic solutions and improved sputum handling.
Why the study?
Unmet needs remain in sputum handling and molecular diagnostics adaptation for resource-limited settings, alongside significant dependence on the Western world for diagnostic needs in India.
This review underscores the critical role of advanced PCR technologies in tuberculosis diagnostics and advocates for the indigenous development of these tools in India to improve accessibility and reduce import dependency.
The advent of Polymerase Chain Reaction (PCR) has revolutionized the human molecular diagnostic scenario. Its ability to exponentially generate desired stretch of DNA from chromosomal or complimentary DNA has laid the foundation for sensitive and specific detection of a pathogen or an aberrant stretch of DNA. Importantly, PCR technology has helped generate diagnostic immunity from phenotypic variation of pathogenic targets. The technological evolution of conventional end-point PCR to its real time version further added clinically important features such as enhanced sensitivity and quantification of target DNA molecules. Two important chemistries became prominent in the real-time PCR domain. The intercalating dye-based chemistry comes with convenience, economy and feature such as melt curve analysis but also carries the disadvantage of overestimation of signal due to unwanted signal from primer dimers. Dual labelled probe on the other hand provides unprecedented sensitivity and specificity. Isothermal method of genome nucleic acid amplification has also evolved as a parallel and convenient method of amplification-based detection of nucleic acid targets. Tuberculosis diagnostics has immensely benefitted from these technologies. However, unmet need exists in sputum handling methods and in its adaptation for molecular diagnostics in resource limited settings. Significant dependence for diagnostic needs on the western world is a matter of concern in India. The country will benefit from rapid and indigenous research and development of molecular diagnostic solutions by way of formulating kits for rapid extraction of DNA and RNA from various clinical sources and developing detection technologies that can compete international products in its category. A solution to address sputum transportation, storage and DNA extraction that has enhanced advantages compared to current methods will also be helpful in the efforts to make India free from tuberculosis.
No takes yet. Share an insight, caveat, or question.
Goyani et al. (2023) conducted a review in Tuberculosis. Polymerase Chain Reaction (PCR) technology was evaluated. Polymerase chain reaction technology has revolutionized tuberculosis diagnostics in India, highlighting a critical need for indigenous development of molecular diagnostic solutions and improved sputum handling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: